BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 22, 2002
View Archived Issues
House Committee Investigating ImClone’s Handling Of Erbitux
WASHINGTON A House committee on Friday said it will investigate New York-based ImClone Systems Inc.’s conduct in the development of its well-publicized drug for colorectal cancer.
Read More
Pharmacopeia, Eos Scrap Merger Following Shareholder Opposition
Read More
Harvard Immunologist, California Firm Join In Hunt For Drugs To Check Human Asthma Onslaught
Read More
BIO’s Agenda Includes Quick Appointment Of FDA Leader
Read More
Holiday Notice
Read More
Other News To Note
Read More
Triangle Plans NDA For One Drug, Discontinues Another
Read More